MUMBAI—The U.S. Food and Drug Administration banned imports from one of the plants of Indian drug maker Wockhardt Ltd., in the latest example of increased global scrutiny of Indian generic drug makers.

Drug regulators in the U.S., the U.K. and elsewhere have been taking a closer look at India's drug companies, which are now the largest supplier of generic drugs to the U.S. and some other countries.